Showing results (491-500 of 1,645) with videos related to
Sort By:
Pageof 165
Therapeutic Innovation & Regulatory Science|September 22, 2018
Interconnectivity of Disparate Nonclinical Data Silos for Drug Discovery and DevelopmentJyotsna Kasturi, Alan P Brown, Paul Brown, et al.Therapeutic Innovation & Regulatory Science|September 22, 2018
The Impact of Collaborative and Risk-Sharing Innovation Approaches on Clinical and Regulatory Cycle TimesJoseph A DiMasi, Jennifer Kim, Kenneth A GetzTherapeutic Innovation & Regulatory Science|September 22, 2018
A Bayesian Stopping Rule for Sequential Monitoring of Serious Adverse EventsKosuke Kashiwabara, Yutaka Matsuyama, Yasuo OhashiTherapeutic Innovation & Regulatory Science|September 22, 2018
Process Investigation of a Novel Compaction Technique With Pellet-Containing GranulesXin Pan, Ying Huang, Yixuan Dong, et al.Therapeutic Innovation & Regulatory Science|September 22, 2018
Social Media Monitoring and Adverse Drug Reaction Reporting in Pharmacovigilance: An Overview of the Regulatory LandscapeMarina Lengsavath, Anne Dal Pra, Anne-Marie de Ferran, et al.Therapeutic Innovation & Regulatory Science|September 22, 2018
The Current Status of Sakigake Designation in Japan, PRIME in the European Union, and Breakthrough Therapy Designation in the United StatesHideyuki Kondo, Toshiyuki Hata, Konomi Ito, et al.Therapeutic Innovation & Regulatory Science|September 22, 2018
Analysis of the Utilization Status of Essential Medicines in Beijing's Community Health InstitutionsFang Zhang, Yu Yang, Shu Chuen LiTherapeutic Innovation & Regulatory Science|September 22, 2018
Innovation of Medical Products: The Evolution of Regulatory Science, Research, and EducationPer Spindler, Karin F Bach, Merete Schmiegelow, et al.Therapeutic Innovation & Regulatory Science|September 22, 2018
Benefits of Centralized ECG Reading in Clinical Oncology StudiesRobert Kleiman, Jeffrey Litwin, Joel MorganrothTherapeutic Innovation & Regulatory Science|September 22, 2018
Studies of Product Structure Adjustment Routes for China's Pharmaceutical Industry: A View From the New Healthcare Reform TargetsWenhua Luo, Lihua Sun, Guangping WangPageof 165